Literature DB >> 745730

Selective intra-arterial cytotostatic injections in malignant head and neck tumors.

J Brismar, A Björklund, A Elner, C M Eneroth.   

Abstract

Regional intra-arterial drug administration has been advocated in order to reduce the risks of systemic complications in conjunction with systemic tumor chemotherapy. We have been using superselective angiographic techniques to administer the antitumor drug mitomycin C directly into the feeding arteries of the tumor in 15 patients with advanced malignant head and neck tumors. No complications were observed. In five patients the tumor decreased significantly in size, in four patients, tumor cell necrosis was found. A marked decrease in pain was reported by nine of the 15 patients.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 745730     DOI: 10.1007/bf00395325

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  8 in total

1.  The management of cervical lymph nodes in head and neck cencer.

Authors:  P M Stell
Journal:  Proc R Soc Med       Date:  1975-02

Review 2.  Mitomycin C: a review.

Authors:  S T Crooke; W T Bradner
Journal:  Cancer Treat Rev       Date:  1976-09       Impact factor: 12.111

3.  Effectiveness of a sequential combination of bleomycin and mitomycin-C on an advanced cervical cancer.

Authors:  T Miyamoto; Y Takabe; M Watanabe; T Terasima
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

Review 4.  The integration of chemotherapy into a combined modality approached to cancer therapy. V. Squamous cell cancer of the head and neck.

Authors:  M A Goldsmith; S K Carter
Journal:  Cancer Treat Rev       Date:  1975-06       Impact factor: 12.111

5.  Treatment of head and neck cancer with intra-arterial cytotoxic drugs and radiotherapy.

Authors:  R Sealy; P Helman
Journal:  Cancer       Date:  1972-07       Impact factor: 6.860

6.  The role of chemotherapy in the management of cancer of the head and neck: a review.

Authors:  J R Bertino; B Boston; R L Capizzi
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

Review 7.  The clinical pharmacology of methotrexate: new applications of an old drug.

Authors:  W A Bleyer
Journal:  Cancer       Date:  1978-01       Impact factor: 6.860

8.  Combination therapy of advanced head and neck cancer: induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapy.

Authors:  V L Randolph; A Vallejo; R H Spiro; J Shah; E W Strong; A G Huvos; R E Wittes
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.